GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » ROA %

VGI Health Technology (XNEC:VTL) ROA % : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. VGI Health Technology's annualized Net Income for the quarter that ended in . 20 was A$ Mil. VGI Health Technology's average Total Assets over the quarter that ended in . 20 was A$ 0 Mil. Therefore, VGI Health Technology's annualized ROA % for the quarter that ended in . 20 was Not Available.

The historical rank and industry rank for VGI Health Technology's ROA % or its related term are showing as below:

XNEC:VTL's ROA % is not ranked *
in the Biotechnology industry.
Industry Median: -34.69
* Ranked among companies with meaningful ROA % only.

VGI Health Technology ROA % Historical Data

The historical data trend for VGI Health Technology's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology ROA % Chart

VGI Health Technology Annual Data
Trend
ROA %

VGI Health Technology Semi-Annual Data
ROA %

Competitive Comparison of VGI Health Technology's ROA %

For the Biotechnology subindustry, VGI Health Technology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VGI Health Technology's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's ROA % distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's ROA % falls into.



VGI Health Technology ROA % Calculation

VGI Health Technology's annualized ROA % for the fiscal year that ended in . 20 is calculated as:

ROA %=Net Income (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

VGI Health Technology's annualized ROA % for the quarter that ended in . 20 is calculated as:

ROA %=Net Income (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (. 20) net income data. ROA % is displayed in the 30-year financial page.


VGI Health Technology  (XNEC:VTL) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

Note: The Net Income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


VGI Health Technology ROA % Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


VGI Health Technology (XNEC:VTL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003
VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines